ARDT Ardent Health, Inc.
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 1756655 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.0%
TTM net income YoY-28.7%
TTM EPS YoY-30.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin2.3%
FCF margin—
EBITDA margin—
Returns
ROE11.1%
ROA2.8%
ROIC (approx.)—
Asset turnover1.23x
Leverage & solvency
Liabilities / assets66.7%
Debt / equity0.79x
Current ratio2.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.30x
Accruals ratio-6.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $6.32B | $5.97B | $5.41B | $5.13B |
| SG&A expense | $140.80M | $132.40M | $114.60M | $75.30M |
| Pretax income | $286.36M | $363.06M | $151.61M | $311.48M |
| Income tax | $56.22M | $63.35M | $22.64M | $46.11M |
| Net income | $135.81M | $210.34M | $53.90M | $188.91M |
| EPS (basic) | 0.96 | 1.59 | 0.43 | 1.50 |
| EPS (diluted) | 0.96 | 1.58 | 0.43 | 1.50 |
| Weighted avg. shares (diluted) | 141.45M | 132.74M | 126.12M | 126.12M |
| Balance sheet | ||||
| Cash & equivalents | $709.60M | $556.78M | $437.58M | $456.12M |
| Receivables | $686.10M | $743.03M | $775.45M | — |
| Inventory | $118.59M | $115.09M | $105.48M | — |
| Current assets | $2.06B | $1.83B | $1.62B | — |
| PP&E, net | $935.77M | $861.90M | $811.09M | — |
| Goodwill | $879.45M | $852.08M | $844.70M | $844.70M |
| Intangibles | $12.40M | — | — | — |
| Total assets | $5.29B | $4.96B | $4.73B | — |
| Current liabilities | $1.05B | $945.42M | $994.10M | — |
| Short-term debt | $23.44M | $9.23M | $18.61M | — |
| Long-term debt | $1.08B | $1.09B | $1.17B | — |
| Total debt | $1.10B | $1.10B | $1.19B | — |
| Total liabilities | $3.61B | $3.43B | $3.65B | — |
| Shareholders' equity | $1.29B | $1.13B | $670.90M | $1.04B |
| Net debt | $389.62M | $538.27M | $749.28M | — |
| Shares outstanding | 142.86M | 142.75M | 0 | — |
| Cash flow statement | ||||
| Operating cash flow | $470.51M | $315.03M | $221.70M | -$38.36M |
| Investing cash flow | -$214.23M | -$220.46M | -$137.98M | $46.58M |
| Financing cash flow | -$103.47M | $24.64M | -$102.26M | -$270.33M |
| Depreciation & amortization | $155.70M | $146.29M | $140.84M | $138.17M |
| Dividends paid | — | $0 | $0 | $174.81M |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.